Clinical Efficacy of Inhaled Nitric Oxide in Preventing the Progression of Moderate to Severe COVID-19 and Its Correlation to Viral Clearance: Results of a Pilot Study

Abstract. Hypoxic patients with coronavirus disease 2019 (COVID-19) are at high risk of adverse outcomes. Inhaled nitric oxide (iNO) has shown anti-viral and immunomodulatory effects in vitro. However, in vivo evidence of efficacy in hypoxic COVID-19 is sparse. This open label feasibility study was...

Full description

Bibliographic Details
Main Authors: Merlin Moni, Thushara Madathil, Dipu T. Sathyapalan, Veena Menon, Georg Gutjahr, Fabia Edathadathil, Deepthi Sureshkumar, Preetha Prasanna, Soumya Jose, Roshni Jerome, Ajai Krishnan, Indulekha C.L. Pillai, Geetha Kumar, Bipin Nair, Victor Nizet, Aveek Jayant, Stijn van der Veen
Format: Article
Language:English
Published: Wolters Kluwer Health 2022-03-01
Series:Infectious Microbes & Diseases
Online Access:http://journals.lww.com/10.1097/IM9.0000000000000079